SMIH
Summit Healthcare Acquisition Corp - Ordinary Shares - Class A

37
Loading...
Loading...
News
all
press releases
News Placeholder
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule YS Biopharma Receives Additional 180 Day Extension by Nasdaq to Regain Compliance with...
PR Newswire·1y ago

Latest SMIH News

View

Advertisement. Remove ads.

Advertisement. Remove ads.